Form 8-K · Current report
Altria 8-K, filed Aug 28, 2026
- Filed
- CIK
- 0000764180
- Accession no.
- 0000764180-26-000098
Summary
Altria Group increased its board of directors from 10 to 11 members and elected Steven W. Presley, currently chief executive of Refresco Benelux B.V. and formerly a Nestlé executive, as an independent director effective August 27, 2026. Presley was also named to the board's Compensation and Talent Development, Innovation and Finance Committees.
Key points
- Altria's board increased from 10 to 11 directors and elected Steven W. Presley effective August 27, 2026.
- Presley was appointed to the board's Compensation and Talent Development, Innovation and Finance Committees.
- The board determined Presley qualifies as an independent director under NYSE listing standards and Altria's independence standards.
- Presley will be compensated under Altria's existing non-employee director compensation program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 27, 2026, the Board of Directors (the “Board”) of Altria Group, Inc. (“Altria”) increased the size of the Board from 10 to 11 directors and elected Steven W. Presley to the Board, in each case, effective August 27, 2026. The Board also elected Mr. Presley to the Board’s Compensation and Talent Development, Innovation and Finance Committees, effective August 27, 2026. The Board affirmatively determined that Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.